PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 27, 2015, Pages 8403-8408

  Salameh, Ahmad ^a,b   Lee, Alessandro K ^a,k   Cardó Vila, Marina ^a,c,d   Nunes, Diana N ^a,e   Efstathiou, Eleni ^a   Staquicini, Fernanda I ^a,c,d   Dobroff, Andrey S ^a,c,d   Marchiò, Serena ^f   Navone, Nora M ^a   Hosoya, Hitomi ^a,l   Lauer, Richard C ^c,d   Wen, Sijin ^a,m   Salmeron, Carolina C ^a,c,d   Hoang, Anh ^a   Newsham, Irene ^a   Lima, Leandro A ^e   Carraro, Dirce M ^e   Oliviero, Salvatore ^g   Kolonin, Mikhail G ^b   Sidman, Richard L ^h   Do, Kim Anh ^a   Troncoso, Patricia ^a   Logothetis, Christopher J ^a   Brentani, Ricardo R ⁿ   Calin, George A ^a   Cavenee, Webster K ⁱ   Dias Neto, Emmanuel ^a,e,j   Pasqualini, Renata ^a,c,d   Arap, Wadih ^a,c,d   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e A C CAMARGO CANCER CENTER   (Brazil)

^f UNIVERSITY OF TURIN   (Italy)

^g Human Genetics Foundation   (Italy)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF SÃO PAULO   (Brazil)

^k Janssen Cilag SpA Italia   (Italy)

^l US Naval Hospital Yokosuka   (Japan)

^m WEST VIRGINIA UNIVERSITY   (United States)

ⁿ NONE

more..

Author keywords

ADAR; Long noncoding RNA; PCA3; Prostate cancer; PRUNE2

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE DEAMINASE ACTING ON RNA; DOUBLE STRANDED RNA; INOSINE; LONG UNTRANSLATED RNA; PROSTATE CANCER ANTIGEN 3; PRUNE2 PROTEIN; TUMOR ANTIGEN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ADAR1 PROTEIN, MOUSE; PROSTATE CANCER ANTIGEN 3, HUMAN; PROTEIN BINDING; PRUNE2 PROTEIN, HUMAN; RNA PRECURSOR; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; GENETIC REGULATION; HUMAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RNA EDITING; ANIMAL; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HELA CELL LINE; IMMUNOBLOTTING; INTRON; MCF 7 CELL LINE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PROCEDURES; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SCID MOUSE; TUMOR CELL LINE;

MUS;

ADENOSINE DEAMINASE; ANIMALS; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HELA CELLS; HUMANS; IMMUNOBLOTTING; INTRONS; MALE; MCF-7 CELLS; MICE, SCID; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA PRECURSORS; RNA, LONG NONCODING; TUMOR SUPPRESSOR PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84936804488     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1507882112     Document Type: Article

References (32)

1. Walsh AL, Tuzova AV, Bolton EM, Lynch TH, Perry AS (2014) Long noncoding RNAs and prostate carcinogenesis: The missing 'linc'? Trends Mol Med 20(8):428-436.
2. Bussemakers MJG, et al. (1999) DD3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 59(23):5975-5979.
3. Wei JT, et al. (2014) Can urinary PCA3 supplement PSA in the early detection of prostate cancer? J Clin Oncol 32(36):4066-4072.
4. Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12(12):861-874.
5. Fatica A, Bozzoni I (2014) Long non-coding RNAs: New players in cell differentiation and development. Nat Rev Genet 15(1):7-21.
6. Geisler S, Coller J (2013) RNA in unexpected places: Long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol 14(11):699-712.
7. Machida T, et al. (2006) Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas. Oncogene 25(13):1931-1942.
8. Clarke RA, et al. (2009) New genomic structure for prostate cancer specific gene PCA3 within BMCC1: Implications for prostate cancer detection and progression. PLoS ONE 4(3):e4995.
9. Lavin MF, Clarke R, Gardiner RA (2009) Differential expression of PCA3 and BMCC1 in prostate cancer. Prostate 69(16):1713-1714, author reply 1715.
10. Salagierski M, et al. (2010) Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer. Prostate 70(1):70-78.
11. Lee YC, et al. (2011) BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res 71(15):5194-5203.
12. Bass BL (2002) RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 71:817-846.
13. Chen L-L, DeCerbo JN, Carmichael GG (2008) Alu element-mediated gene silencing. EMBO J 27(12):1694-1705.
14. Mallela A, Nishikura K (2012) A-to-I editing of protein coding and noncoding RNAs. Crit Rev Biochem Mol Biol 47(6):493-501.
15. Ferreira LB, et al. (2012) PCA3 noncoding RNA is involved in the control of prostatecancer cell survival and modulates androgen receptor signaling. BMC Cancer 12:507.
16. Soh UJ, Low BC (2008) BNIP2 extra long inhibits RhoA and cellular transformation by Lbc RhoGEF via its BCH domain. J Cell Sci 121(Pt 10):1739-1749.
17. Galasso A, Zollo M (2009) The Nm23-H1-h-Prune complex in cellular physiology: A 'tip of the iceberg' protein network perspective. Mol Cell Biochem 329(1-2):149-159.
18. Basile JR, Gavard J, Gutkind JS (2007) Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility. J Biol Chem 282(48):34888-34895.
19. Rhodes DR, et al. (2004) ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia 6(1):1-6.
20. Taylor BS, et al. (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18(1):11-22.
21. Cech TR, Steitz JA (2014) The noncoding RNA revolution-trashing old rules to forge new ones. Cell 157(1):77-94.
22. Guttman M, et al. (2011) lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477(7364):295-300.
23. Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: Insights into functions. Nat Rev Genet 10(3):155-159.
24. Ponting CP, Oliver PL, ReikW(2009) Evolution and functions of long noncoding RNAs. Cell 136(4):629-641.
25. Iwama E, et al. (2011) Cancer-related PRUNE2 protein is associated with nucleotides and is highly expressed in mature nerve tissues. J Mol Neurosci 44(2):103-114.
26. Arama J, et al. (2012) Bmcc1s, a novel brain-isoform of Bmcc1, affects cell morphology by regulating MAP6/STOP functions. PLoS ONE 7(4):e35488.
27. Harris JL, et al. (2013) BMCC1 is an AP-2 associated endosomal protein in prostate cancer cells. PLoS ONE 8(9):e73880.
28. Pan CQ, Low BC (2012) Functional plasticity of the BNIP-2 and Cdc42GAP Homology (BCH) domain in cell signaling and cell dynamics. FEBS Lett 586(17):2674-2691.
29. Knudson AG, Jr (1971) Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68(4):820-823.
30. Cavenee WK, et al. (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305(5937):779-784.
31. Berger AH, Knudson AG, Pandolfi PP (2011) A continuum model for tumour suppression. Nature 476(7359):163-169.
32. Li B, Dewey CN (2011) RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12:323.